Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
1997 3
2000 2
2002 1
2003 1
2004 1
2005 1
2006 1
2007 5
2008 3
2009 8
2010 3
2012 5
2013 4
2014 4
2015 7
2016 9
2017 13
2018 14
2019 12
2020 11
2021 11
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Results by year
Filters applied: . Clear all
Page 1
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders.
Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, Erichsen HC, Forbes LR, Gu S, Yuan B, Jhangiani SN, Muzny DM, Rødningen OK, Sheng Y, Nicholas SK, Noroski LM, Seeborg FO, Davis CM, Canter DL, Mace EM, Vece TJ, Allen CE, Abhyankar HA, Boone PM, Beck CR, Wiszniewski W, Fevang B, Aukrust P, Tjønnfjord GE, Gedde-Dahl T, Hjorth-Hansen H, Dybedal I, Nordøy I, Jørgensen SF, Abrahamsen TG, Øverland T, Bechensteen AG, Skogen V, Osnes LTN, Kulseth MA, Prescott TE, Rustad CF, Heimdal KR, Belmont JW, Rider NL, Chinen J, Cao TN, Smith EA, Caldirola MS, Bezrodnik L, Lugo Reyes SO, Espinosa Rosales FJ, Guerrero-Cursaru ND, Pedroza LA, Poli CM, Franco JL, Trujillo Vargas CM, Aldave Becerra JC, Wright N, Issekutz TB, Issekutz AC, Abbott J, Caldwell JW, Bayer DK, Chan AY, Aiuti A, Cancrini C, Holmberg E, West C, Burstedt M, Karaca E, Yesil G, Artac H, Bayram Y, Atik MM, Eldomery MK, Ehlayel MS, Jolles S, Flatø B, Bertuch AA, Hanson IC, Zhang VW, Wong LJ, Hu J, Walkiewicz M, Yang Y, Eng CM, Boerwinkle E, Gibbs RA, Shearer WT, Lyle R, Orange JS, Lupski JR. Stray-Pedersen A, et al. Among authors: fevang b. J Allergy Clin Immunol. 2017 Jan;139(1):232-245. doi: 10.1016/j.jaci.2016.05.042. Epub 2016 Jul 16. J Allergy Clin Immunol. 2017. PMID: 27577878 Free PMC article.
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial.
Goll GL, Jørgensen KK, Sexton J, Olsen IC, Bolstad N, Haavardsholm EA, Lundin KEA, Tveit KS, Lorentzen M, Berset IP, Fevang BTS, Kalstad S, Ryggen K, Warren DJ, Klaasen RA, Asak Ø, Baigh S, Blomgren IM, Brenna Ø, Bruun TJ, Dvergsnes K, Frigstad SO, Hansen IM, Hatten ISH, Huppertz-Hauss G, Henriksen M, Hoie SS, Krogh J, Midtgard IP, Mielnik P, Moum B, Noraberg G, Poyan A, Prestegård U, Rashid HU, Strand EK, Skjetne K, Seeberg KA, Torp R, Ystrøm CM, Vold C, Zettel CC, Waksvik K, Gulbrandsen B, Hagfors J, Mørk C, Jahnsen J, Kvien TK. Goll GL, et al. Among authors: fevang bts. J Intern Med. 2019 Jun;285(6):653-669. doi: 10.1111/joim.12880. Epub 2019 Apr 12. J Intern Med. 2019. PMID: 30762274 Free PMC article. Clinical Trial.
Open access - elefanten (eller isbjørnen) i rommet.
Fevang B. Fevang B. Tidsskr Nor Laegeforen. 2018 Jan 22;138(2). doi: 10.4045/tidsskr.18.0019. Print 2018 Jan 23. Tidsskr Nor Laegeforen. 2018. PMID: 29357620 Free article. Norwegian. No abstract available.
Granulomatous-lymphocytic interstitial lung disease: an international research prioritisation.
Hurst JR, Abbas SH, Bintalib HM, Alfaro TM, Baumann U, Burns SO, Condliffe A, Davidsen JR, Fevang B, Gennery AR, Haerynck F, Jacob J, Jolles S, Lamers O, Bergeron A, Malphettes M, Meignin V, Milito C, Milota T, Pergent M, Prasse A, Quinti I, Renzoni E, Sediva A, Stolz D, Smits B, Strauss F, van de Ven AAJM, van Montfrans J, Warnatz K. Hurst JR, et al. Among authors: fevang b. ERJ Open Res. 2021 Dec 6;7(4):00467-2021. doi: 10.1183/23120541.00467-2021. eCollection 2021 Oct. ERJ Open Res. 2021. PMID: 34881327 Free PMC article.
Structured patient care pathway for gout.
Lianes O, Nystad TW, Røen SA, Fevang BS. Lianes O, et al. Among authors: fevang bs. Tidsskr Nor Laegeforen. 2020 Feb 3;140(2). doi: 10.4045/tidsskr.19.0078. Print 2020 Feb 4. Tidsskr Nor Laegeforen. 2020. PMID: 32026858 Free article. English, Norwegian.
COVID-19 in patients with chronic inflammatory rheumatic joint disease.
Nystad TW, Hufthammer KO, Buanes EA, Bryne K, Fevang BS. Nystad TW, et al. Among authors: fevang bs. Tidsskr Nor Laegeforen. 2021 Oct 11;141(2021-14). doi: 10.4045/tidsskr.21.0362. Print 2021 Oct 12. Tidsskr Nor Laegeforen. 2021. PMID: 34641647 Free article. English, Norwegian.
CVID and Celiac Disease.
Jørgensen SF, Reims HM, Aukrust P, Lundin KE, Fevang B. Jørgensen SF, et al. Among authors: fevang b. Am J Gastroenterol. 2017 Feb;112(2):393. doi: 10.1038/ajg.2016.551. Am J Gastroenterol. 2017. PMID: 28154406 No abstract available.
Elevated plasma sTIM-3 levels in patients with severe COVID-19.
Ueland T, Heggelund L, Lind A, Holten AR, Tonby K, Michelsen AE, Jenum S, Jørgensen MJ, Barratt-Due A, Skeie LG, Nordøy I, Aanensen Fraz MS, Quist-Paulsen E E, Pischke SE, Johal SK, Hesstvedt L, Bogen M, Fevang B, Halvorsen B, Müller F, Bekken GK, Mollnes TE, Dudman S, Aukrust P, Dyrhol-Riise AM, Holter JC. Ueland T, et al. Among authors: fevang b. J Allergy Clin Immunol. 2021 Jan;147(1):92-98. doi: 10.1016/j.jaci.2020.09.007. Epub 2020 Sep 21. J Allergy Clin Immunol. 2021. PMID: 32971109 Free PMC article. Clinical Trial.
106 results